Outcomes of Endolymphatic Shunt Surgery for Meniere's Disease: Comparison With Intratympanic Gentamicin on Vertigo Control and Hearing Loss

被引:15
|
作者
Derebery, M. Jennifer [1 ,2 ]
Fisher, Laurel M. [1 ]
Berliner, Karen [1 ]
Chung, Janice [3 ]
Green, Katherine [3 ]
机构
[1] House Ear Res Inst, Los Angeles, CA 90057 USA
[2] House Ear Clin, Los Angeles, CA USA
[3] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA
关键词
Endolymphatic shunt surgery; Gentamicin; Meniere's disease; MASTOID SHUNT; SAC SURGERY; SURGICAL-MANAGEMENT; SUBARACHNOID SHUNT; THERAPY; MUTATION; DECOMPRESSION; METAANALYSIS; PATIENT; ERA;
D O I
10.1097/MAO.0b013e3181dd13ac
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To compare proportions of the combined outcome of vertigo control and hearing preservation between intratympanic gentamicin injections and endolymphatic sac shunt surgery for intractable vertigo in Meniere's disease patients. Study Design: Analysis of published data and retrospective review. Setting: Tertiary otologic referral center. Patients: Patients with Meniere's disease who had failed medical management: 183 surgical patients (shunt group) and 203 patients obtained from 6 published gentamicin treatment studies (gentamicin group). Cases were included if hearing and vertigo data were available before and after treatment with no previous surgical or injection treatment. Average patient age ranged from 45 to 59 years across studies. Gentamicin studies had nearly equal female to male subjects, whereas the shunt group was 60% female. Interventions: Endolymphatic sac shunt surgery or intratympanic gentamicin treatment of differing doses and injection schedules. Main Outcome Measure: Proportion of patients with best combined vertigo control/hearing preservation. Hearing preservation is 10 dB or less increase in pure-tone average. Outcomes were categorized as follows: complete vertigo control/hearing preservation (best), complete vertigo control/hearing loss, incomplete vertigo control/hearing preservation, and incomplete vertigo control/hearing loss (worst). Results: The shunt group showed a significantly higher percentage of the best outcome (62%) than the gentamicin group (56%, p <= 0.003), as well as a higher rate of complete vertigo control (86% versus 71%; p <= 0.001). Conclusion: A higher percentage of patients undergoing shunt surgery attained complete vertigo control/hearing preservation relative to intratympanic gentamicin. There continues to be significant variability in gentamicin outcomes, suggesting that the technique requires additional refinement before consistently producing good outcomes.
引用
收藏
页码:649 / 655
页数:7
相关论文
共 50 条
  • [31] Comparison of Intratympanic Methylprednisolone and Gentamicin for Meniere's Disease May Be Misleading
    Crane, Benjamin T.
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2013, 149 (01) : 175 - 175
  • [32] Comparing Intratympanic Gentamicin with Methylprednisolone in Meniere's Disease with Non-Serviceable Hearing
    Thomas, Leah
    Lepcha, Anjali
    Reka, K.
    Augustine, Ann Mary
    Alex, Anu
    Philip, Ajay
    Mammen, Manju Deena
    [J]. INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2022, 74 (SUPPL 3) : 3738 - 3745
  • [33] Comparing Intratympanic Gentamicin with Methylprednisolone in Meniere’s Disease with Non-Serviceable Hearing
    Leah Thomas
    Anjali Lepcha
    K. Reka
    Ann Mary Augustine
    Anu Alex
    Ajay Philip
    Manju Deena Mammen
    [J]. Indian Journal of Otolaryngology and Head & Neck Surgery, 2022, 74 : 3738 - 3745
  • [34] Low Dose Intratympanic Gentamicin in Meniere's Disease
    Faizal, Bini
    Rajan, Afsha
    [J]. INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2022, 74 (SUPPL 1) : 320 - 325
  • [35] Systematic review of intratympanic gentamicin in Meniere's disease
    Diamond, C
    O'Connell, DA
    Hornig, JD
    Liu, R
    [J]. JOURNAL OF OTOLARYNGOLOGY, 2003, 32 (06): : 351 - 361
  • [36] Intratympanic gentamicin injection for the treatment of Meniere's disease
    Youssef, TE
    Poe, DS
    [J]. AMERICAN JOURNAL OF OTOLOGY, 1998, 19 (04): : 435 - 442
  • [37] Intratympanic gentamicin in Meniere's disease: Results of therapy
    Murofushi, T
    Halmagyi, GM
    Yavor, RA
    [J]. AMERICAN JOURNAL OF OTOLOGY, 1997, 18 (01): : 52 - 57
  • [38] Intratympanic gentamicin in Meniere's disease: the impact on tinnitus
    Yetiser, S
    Kertmen, M
    [J]. INTERNATIONAL JOURNAL OF AUDIOLOGY, 2002, 41 (06) : 363 - 370
  • [39] Intratympanic gentamicin compared with placebo for Meniere's disease
    de Amesti, Fernanda
    Santander, Maria Jesus
    Winter, Matias
    [J]. MEDWAVE, 2022, 22 (02):
  • [40] Intratympanic gentamicin therapy for intractable Meniere's disease
    De Beer, Lieke
    Stokroos, Robert
    Kingma, Herman
    [J]. ACTA OTO-LARYNGOLOGICA, 2007, 127 (06) : 605 - 612